Trials / Withdrawn
WithdrawnNCT00123175
Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)
Levonorgestrel Containing Intrauterine Device in the Treatment of Endometrial Hyperplasia Without Atypia
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Milton S. Hershey Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to determine the effectiveness of the intrauterine device (IUD) called Mirena when compared to the Provera tablets used in treating this condition.
Detailed description
Endometrial hyperplasia without atypia is a condition usually caused by excessive stimulation of the uterine lining (endometrium) by estrogens, and may cause irregular bleeding as a presenting symptom, but rarely may progress to endometrial cancer, which makes treatment important. The only treatment approved so far is medroxyprogesterone acetate tablets (progesterone), also known as Provera.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intrauterine Device | Mirena and Provera |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2005-07-22
- Last updated
- 2013-01-08
Source: ClinicalTrials.gov record NCT00123175. Inclusion in this directory is not an endorsement.